Maedi-visna virus and its relationship to human immunodeficiency virus

AIDS Reviews

Volumn 7, Issue 4, 2005, Pages 233-245

  Thormar, Halldor ^a  

^a UNIVERSITY OF ICELAND   (Iceland)

Author keywords

HIV 1; Maedi visna; MVV; Ovine lentiviruses

Indexed keywords

ADEFOVIR; DNA VACCINE; GAG PROTEIN; POL PROTEIN; REV PROTEIN; TRANSACTIVATOR PROTEIN; VACCINIA VACCINE; VIF PROTEIN; VIRUS ENVELOPE PROTEIN;

BONE MARROW; CAPRINE ARTHRITIS ENCEPHALITIS VIRUS; CENTRAL NERVOUS SYSTEM INFECTION; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; DNA TRANSCRIPTION; EUROPE; GENE CONTROL; GENE FUNCTION; GOAT DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNE RESPONSE; INFECTION CONTROL; INFECTIOUS ARTHRITIS; INTERSTITIAL PNEUMONIA; LENTIVIRINAE; LYMPHOCYTE DEPLETION; LYMPHOPROLIFERATIVE DISEASE; MACROPHAGE; MASTITIS; MONOCYTE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; RETROVIRUS; REVIEW; SEQUENCE HOMOLOGY; SHEEP DISEASE; UNITED STATES; VIRUS GENE; VIRUS INFECTION; VIRUS REPLICATION; VIRUS TRANSMISSION; VISNA VIRUS;

ANIMALS; DISEASE MODELS, ANIMAL; HIV; HIV INFECTIONS; HUMANS; PNEUMONIA, PROGRESSIVE INTERSTITIAL, OF SHEEP; SHEEP; VIRAL PROTEINS; VISNA; VISNA-MAEDI VIRUS;

EID: 30944446249     PISSN: 11396121     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (144)

1. Pálsson P. Maedi and visna in sheep. In: Kimberlin RH ed. Slow virus diseases of animals and man. North Holland Publishing Comp. Amsterdam, 1976. pp. 17-43.
2. Sigurdsson B, Pálsson P, Tryggvadóttir A. Transmission experiments with maedi. J Infect Dis 1953;93:166-75.
3. Sigurdsson B, Pálsson P. Visna of sheep. A slow, demyelinating infection. Brit J Exp Pathol 1958;39:519-28.
4. Sigurdsson B. Rida: a chronic encephalitis of sheep. With general remarks on infections which develop slowly and some of their special characteristics. Brit Vet J 1954;110:341-54.
5. Thormar H. Physical, chemical and biological properties of visna virus and its relationship to other animal viruses. In: Slow, latent and temperate virus infections. NINDB Monograph No.2, US Public Health Service, Washington 1966. pp. 335-340.
6. Mitchell DT. Investigations into jaagsiekte or chronic catarrhal-pneumonia of sheep. 3rd and 4th Reps. Vet Res S Afr 1915:585-614.
7. Marsh H. Progressive pneumonia in sheep. J Am Vet Assoc 1923;62:458-73.
8. Lucam F. La"bouhite" ou "lymphomatose pulmonaire maligne du Mouton". Réc Méd Vét 1942;118:273-84.
9. Ressang A, De Boer G, Wijn G. The lung in zwoegerziekte. Path Vet 1968;5:353-69.
10. De Boer G. Zwoegerziekte. Een persisterende virusinfectie bij schapen. Thesis. Utrecht, 1970.
11. Koens H. De "Zwoegers" op Texel. Thesis, Utrecht. 1943.
12. Brodie S, de la Concha-Bermejillo A, Snowder G, DeMartini J. Current topics in epizootiology, diagnosis, and economic importance of OPP in North America: A review. Small Ruminant Res 1998;27:1-17.
13. Straub O. MVV infection in sheep. History and present knowledge. Comp Immunol Microbiol & Infect Dis 2004;27:1-5.
14. Ressang A, Stam F, De Boer G. A meningo-leukoencephalomyelitis resembling visna in Dutch Zwoeger sheep. Path Vet 1966;3:401-11.
15. Brodie S, Bickle H, DeMartini J. Virologic markers in CSF are predictive of OvLV-associated subclinical encephalomyelitis. Clin Immunol Immunopathol 1995;77:14-18.
16. Schaltenbrand G, Straub O. Visna/maedi in einer unterfränkischen Merinofleischschafherde. Deutsche Tierärtzl Wochenschr 1972;79:10-12.
17. Sharma D, Rajya B, Dwivedi J. Patho-anatomical studies of meningo-leuco encephalitis in maedi of sheep and goat. Indian J Anim Sci 1974;44:480-4.
18. Peterhans E, Greenland T, Badiola J, et al. Routes of transmission and consequences of small ruminant lentiviruses (SRLVs) infection and eradication schemes. Vet Res 2004;35:257-74.
19. Sigurdsson B, Grímsson H, Pálsson P. Maedi, a chronic progressive infection of sheep's lungs. J Infect Dis 1952;90:233-41.
20. Georgsson G, Nathanson N, Pálsson P; Pétursson G. The pathology of visna and maedi in sheep In: Kimberlin RH ed. Slow virus diseases of animals and man. North Holland Publishing Comp. Amsterdam, 1976. pp. 61-96.
21. Gíslason G. Thaettir um innflutning búfjár og Karakúlsjúkdóma. Iceland Ministry of Agriculture Publ. Reykjavik, 1947:235-54.
22. Sigurdsson B, Pálsson P, Grímsson H. Visna, a demyelinating transmissible disease of sheep. J. Neuropathol Exp Neurol 1957;16:389-403.
23. Deng P, Cutlip R, Lehmkuhl H, Brogden K. Ultrastructure and frequency of mastitis caused by OPP virus infection in sheep. Vet Pathol 1986;23:184-9.
24. Oliver R, Gorham J, Parish S, Hadlow W, Narayan O. OPP: pathologic and virologic studies of the naturally occurring disease. Am JVet Res 1981;42:1554-9.
25. Houwers D, Pekelder J, Akkermans J, van der Molen E, Schreuder B. Incidence of indurative lymphocytic mastitis in a flock of sheep infected with MVV. Vet Res 1988;122:435-7.
26. Crawford TB, Adams DS, Cheevers WP, Cork LC. Chronic arthritis in goats caused by a retrovirus. Science 1980;207:997-9.
27. Crawford T, Adams D. CAE: clinical features and presence of antibody in selected populations. J Am Vet Med Assoc 1981;178:713-9.
28. Pépin M, Vitu C, Russo P, Mornex J-F, Peterhans E. MVV infection in sheep. A review. Vet Res 1998;29:341-67.
29. Alvarez V, Arranz J, Daltabuit-Test M, et al. Relative contribution of colostrum from MVV-infected ewes to MVV-seroprevalence in lambs. Res Vet Sci 2004;78:237-43.
30. Preziuso S, Renzoni G, Allen T, et al. Colostral transmission of MVV: sites of viral entry in lambs born from experimentally infected ewes. Vet Microbiol 2004;104:157-64.
31. Cutlip R, Lehmkuhl H, Jackson T. Intrauterine transmission of OPP virus. Am J Vet Res 1981;42:1795-7.
32. Brodie S, de la Concha-Bermejillo A, Koenig G, Snowder G, DeMartini J. Maternal factors associated with prenatal transmission of OvLV. J Infect Dis 1994;169:653-7.
33. Houwers D, Koenig G, De Boer G, Schaake J Jr. Maedi-visna control in sheep. Artificial rearing of colostrum-deprived lambs. Vet Microbiol 1983;8:179-85.
34. Houwers D, König C, de Boer M, et al. Maedi-visna control in sheep III. Results and evaluation of a voluntary control program in the Netherlands over a period of four years. Vet Q 1987;9 Suppl:28S-36S.
35. De Boer G, Terpstra C, Houwers D, Hendriks J. Studies in epidemiology of maedi-visna in sheep. Res Vet Sci 1979;26:202-8.
36. De la Concha-Bermejillo A, Magnus-Corral S, Brodie S, DeMartini J. Venereal shedding of OvLV in infected rams. Am J Vet Res 1996;57:684-8.
37. Banks K, Adams D, McGuire T, Carlson J. Experimental infection of sheep by CAE virus and goats by progressive pneumonia virus. Am J Vet Res 1983;44:2307-11.
38. Shah C, Huder J, Böni J, et al. Direct evidence for natural transmission of small-ruminant lentiviruses of subtype A4 from goats to sheep and vice versa. J Virol 2004;78:7518-22.
39. Thormar H, von Magnus H. Neutralization of visna virus by human sera. Acta Pathol Microbiol Scand 1963;57:261-7.
40. Cutlip R, Lehmkuhl H, Brogden K, Schmerr M. Seroprevalence of OPP virus in various domestic and wild animal species, and species susceptibility to the virus. Am J Vet Res 1991;52:189-91.
41. Zink M, Johnson L. Pathobiology of lentivirus infection of sheep and goats. Virus Res 1994;32:139-54.
42. Houwers D, Visscher A, Defize P. Importance of ewe/lamb relationship and breed in the epidemiology of MVV infections. Res Vet Sci 1989;46:5-8.
43. Cutlip R, Lehmkuhl H, Brogden K, Sacks J. Breed susceptibility to OPP (maedi-visna) virus. Vet Microbiol 1986;12:283-8.
44. Cutlip R, Lehmkuhl H. Eradication of OPP from sheep flocks. JAVMA 1986;188:1026-7.
45. Pétursson G, Matthíasdóttir S, Svansson V, et al. Mucosal vaccination with an attenuated MVV clone. Vaccine 2005;23:3223-8.
46. Thormar H, Georgsson G, Pálsson P, et al. Inhibitory effect of PMEA on visna virus infection in lambs: A model for in vivo testing of candidate anti-HIV drugs. Proc Natl Acad Sci USA 1995;92:3283-7.
47. Thormar H, Georgsson G, Gunnarsson E, et al. Treatment of visna virus infection in lambs with the acyclic nucleoside phosphonate analogue PMEA. Antiviral Chem Chemother 1998;9:245-52.
48. Thormar H, Georgsson G, Pálsson P, et al. Visna in sheep as a model for chemotherapy of lentiviral CNS infections. Clin Microbiol Infect 1998;4:618-21.
49. Pétursson G, Nathanson N, Georgsson G, Panitch H, Pálsson P. Pathogenesis of visna. Sequential virologic, serologic, and pathologic studies. Lab Invest 1976;35:402-12.
50. Gudnadóttir M, Pálsson P. Successful transmission of visna by intrapulmonary inoculation. J Infect Dis 1965;115:217-25.
51. Gudnadóttir M, Pálsson P. Transmission of maedi by inoculation of virus grown in tissue culture from maedi-affected lungs. J Infect Dis 1967;117:1-6.
52. Gudnadóttir M, Kristinsdóttir K. Complement-fixing antibodies in sera of sheep affected with visna and maedi. J Immunol 1967;98:663-7.
53. Torsteinsdóttir S, Georgsson G, Gísladóttir E, Rafnar B, Pálsson P, Pétursson G. Pathogenesis of CNS lesions in visna: cell-mediated immunity and lymphocyte subsets in blood, brain and CSF. J Neuroimmunol 1992;41:149-58.
54. Griffin D, Narayan O, Adams R. Early immune response in visna, a slow viral disease of sheep. J Infect Dis 1978;138:340-50.
55. Blacklaws B, Bird P, Allen D, et al. Initial lentivirus-host interactions within lymph nodes: a study of MVV infection in sheep. J Virol 1995;69:1400-7.
56. Narayan O, Wolinsky J, Clements J, Strandberg J, Griffin D, Cork L. Slow virus replication: the role of macrophages in the persistence and expression of visna viruses of sheep and goats. J Gen Virol 1982;59:345-56.
57. Gendelman H, Narayan O, Molineaux S, Clements J, Ghotbi Z. Slow, persistent replication of lentiviruses: Role of tissue macrophages and macrophage precursors in bone marrow. Proc Natl Acad Sci USA 1985;82:7086-90.
58. Gendelman H, Narayan O, Kennedy-Stoskopf S, et al. Tropism of sheep lentivirus for monocytes: Susceptibility to infection and virus gene expression increase during maturation of monocytes to macrophages. J Virol 1986;58:67-74.
59. Haase A, Stowring L, Narayan O, Griffin D, Price D. Slow persistent infection caused by visna virus: role of host restriction. Science 1977;195:175-7.
60. Peluso R, Haase A, Stowring L, Edwards M, Ventura P. A Trojan-horse mechanism for the spread of visna virus in monocytes. Virology 1985;147:231-6.
61. Clements J, Zink M, Narayan O, Gabuzda DH. Lentivirus infection of macrophages. Immunol Ser 1994;60:589-600.
62. Georgsson G, Houwers D, Pálsson P, Pétursson P. Expression of viral antigens in the CNS of visna-infected sheep: a histochemical study on experimental visna induced by virus strains of increased neurovirulence. Acta Neuropathol 1989;77:299-306.
63. Clements J, Zink M. Molecular biology and pathogenesis of animal lentivirus infections. Clin Microbiol Rev 1996;9:100-17.
64. Carrozza M, Mazzei M, Bandecchi P, Arispici M, Tolari F. In situ PCR-associated immunohistochemistry identifies cell types harboring the MVV genome in tissue sections of sheep infected naturally. J Virol Methods 2003;107:121-7.
65. Gorrell M, Brandon M, Sheffer D, Adams R, Narayan O. OvLV is macrophage tropic and does not replicate productively in T lymphocytes. J Virol 1992;66:2679-88.
66. Ryan S, Tiley L, McConnell I, Blacklaws B. Infection of dendritic cells by the maedi-visna lentivirus. J Virol 2000;74:10096-103.
67. Lyall J, Solanky N, Tiley L. Restricted species tropism of MVV strain EV-1 is not due to limited receptor distribution. J Gen Virol 2000; 81:2919-27.
68. Hotzel I, Cheevers W. A MVV strain K1514 receptor gene is located in sheep chromosome 3p and the syntenic region of human chromosome 2. J Gen Virol 2002;83:1759-64.
69. Thormar H, Sigurdardóttir B. Growth of visna virus in primary tissue cultures from various animal species. Acta Microblol Pathol Scand 1962;55:180-6.
70. Agnarsdóttir G, Thorsteinsdóttir H, Óskarssson T, et al. The LTR is a determinant of cell tropism of MVV. J GenVirol 2000;81:1901-5.
71. Brodie S, Pearson L, Zink M, et al. OvLV expression and disease. Virus replication, but not entry, is restricted to macrophages of specific tissues. Am J Pathol 1995;146:250-63.
72. Gudnadóttir M. Visna-maedi in sheep. Prog Med Virol 1974;18:336-49.
73. Narayan O, Griffin D, Chase J. Antigenic shift of visna virus in persistently infected sheep. Science 1977;197:376-8.
74. Lutley R, Pétursson G, Pálsson P, Georgsson G, Klein J, Nathanson N. Antigenic drift in visna: virus variation during long-term infection of Icelandic sheep. J Gen Virol 1983;64:1433-40.
75. Thormar H, Barshatzky M, Arnesen K, Kozlowski P. The emergence of antigenic variants is a rare event in long-term visna virus infection in vivo. J Gen Virol 1983;64:1427-32.
76. Thormar H. Neutralization of visna virus by antisera from sheep. J Immunol 1963;90:185-92.
77. Kennedy-Stoskopf S, Narayan O. Neutralizing antibodies to visna lentivirus: mechanism of action and possible role in virus persistence. J Virol 1986;59:37-44.
78. Singh D, Chebloune Y, Mselli-Lakhal L, Karr M, Narayan O. OvLV-infected macrophages mediate productive infection in cell types that are not susceptible to infection with free virus. J Gen Virol 1999;80:1437-44.
79. Nathanson N, Panitch H, Pálsson P, Pétursson G, Georgsson G. Pathogenesis of visna. Effect of immunosuppression upon early CNS lesions. Lab Invest 1976;35:444-51.
80. Pétursson G, Nathanson N, Pálsson P, Martin J, Georgsson, G. Immunopathogenesis of visna. A slow virus disease of the CNS. Acta Neurol Scand 1978;57 Suppl 67:205-19.
81. Georgsson G, Nathanson N, Pétursson G, Martin J, Pálsson P. The immunopathogenesis of visna. In: Rose FD and Behan PO ed. Animal models of neurological disease. Pitman Medical, London. 1980 pp. 378-89.
82. Stowring L, Haase A, Pétursson G, et al. Detection of visna antigens and RNA in glial cells in foci of demyelination. Virology 1985;141:311-8.
83. Haase A. Pathogenesis of lentivirus infections. Nature (London) 1986;322:130-6.
84. Lairmore M, Akita G, Russell H, DeMartini J. Replication and cytopathic effects of OvLV strains in alveolar macrophages correlate with in vivo pathogenicity. J Virol 1987;61:4038-42.
85. Brodie S, Marcom K, Pearson L, et al. Effects of virus load in the pathogenicity of lentivirus-induced lymphoid interstitial pneumonia. J Infect Dis 1992;166:531-41.
86. Zhang Z, Watt N, Hopkins J, Harkiss G, Woodall C. Quantitative analysis of MVV DNA load in peripheral blood monocytes and alveolar macrophages. J Virol Methods 2000;86:13-20.
87. Blacklaws B, Bird P, Allen D, McConnell I. Circulating CTL in MVV-infected sheep. J Gen Virol 1994;75:1589-96.
88. Narayan O, Zink M, Gorrell M, McEntee M, Sharma D, Adams R. Lentivirus induced arthritis in animals. J Rheumatol 1992;32 Suppl:25-32.
89. Pétursson O, Andrésdóttir V, Andrésson Ó, et al. Lentivirus diseases of sheep and goats: MVV and CAE. In: Speedy AW. ed. Progress in sheep and goat research. C.A.B. International, Wallingford. 1992, pp. 107-129.
90. Bergsteinsdóttir K, Árnadóttir S, Torsteinsdóttir S, et al. Constitutive and visna virus induced expression of class I and II MHC antigens in the CNS of sheep and their role in the pathogenesis of visna lesions. Neuropathol Appl Neurobiol 1998;24:224-32.
91. Sigurdsson B, Thormar H, Pálsson P. Cultivation of visna virus in tissue culture. Arch Gas Virusforsch 1960;10:368-81.
92. Sigurdardóttir B, Thormar H. Isolation of a viral agent from the lungs of sheep affected with maedi. J Infect Dis 1964;114:55-60.
93. Thormar H. A comparison of visna and maedi viruses I. Physical, chemical and biological properties. Res Vet Sci 1965;6:117-129.
94. Thormar H. An electron microscope study of tissue cultures infected with visna virus. Virology 1961;14:463-75.
95. Thormar H, Helgadóttir H. A comparison of visna and maedi viruses II. Serological relationship. Res Vet Sci 1965;6:456-65.
96. Lin F, Thormar H. RNA-dependent DNA polymerase in visna virus. J Virol 1970;6:702-4.
97. Lin F, Thormar H. Characterization of RNA from visna virus. J Virol 1971;7:582-7.
98. Lin F, Thormar H. Properties of maedi nucleic acid and the presence of RNA- and DNA-dependent DNA polymerase in the virions. J Virol 1972;10:228-33.
99. Mountcastle W, Harter D, Choppin P. The proteins of visna virus. Virology 1972;47:542-5.
100. Haase A. The slow infection caused by visna virus. Curr Top Microbiol Immunol 1975;72:101-56.
101. Vigne R, Filippi P, Querat G, et al. Precursor polypeptides to structural proteins of visna virus. J Virol 1982;42:1046-56.
102. Kennedy R, Eklund C, Lopez C, Hadlow W. Isolation of a virus from the lungs of Montana sheep affected with OPP. Virology 1968;35:483-4.
103. Lopez C, Eklund C, Hadlow W. Tissue culture studies of the virus of OPP, a slow infectious disease of sheep. Proc Soc Exp Biol Med 1971;138:1035-40.
104. Takemoto K, Mattern C, Stone L, Coe J, Lavelle G. Antigenic and morphological similarities of OPP virus, a recently isolated "slow virus" of sheep, to visna and maedi viruses. J Virol 1971;7:301-8.
105. Cutlip R, Laird G. Isolation and characterization of a virus associated with OPP (maedi) of sheep. Am J Vet Res 1976;37:1377-82.
106. Thormar H. A study of maedi virus. Proc. 3rd Int. Conf. on Lung Tumors in Animals. A publication of the Division of Cancer Research, University of Perugia, Italy, 1966. pp. 393-402.
107. Georgsson G, Pálsson P. The histopathology of maedi, a slow viral pneumonia of sheep. Vet Path 1971;8:63-80.
108. Brown H, Thormar H. Persistence of visna virus in murine and hamster cell cultures without the appearance of cell transformation. Microbios 1975;13:51-60.
109. Trowbridge R. A long-term visna virus infection of sheep choroid plexus (SCP) cells: Initiation and preliminary characterization of the carrier culture. Infect Immun 1975;11:862-8.
110. Haase A, Varmus H. Demonstration of a DNA provirus in the lytic growth of visna virus. Nature New Biol 1973;245:237-9.
111. Haase A, Traynor B, Ventura P, Alling D. Infectivity of visna virus DNA. Virology 1976;70:65-79.
112. Sonigo P, Alizon M, Staskus K, et al. Nucleotide sequence of the visna lentivirus: Relationship to the AIDS virus. Cell 1985;42:369-82.
113. Tiley L, Malim M, Cullen B. Conserved functional organization of the HIV type-1 and visna virus Rev proteins. J Virol 1991;65:3877-81.
114. Toohey K, Haase A. The rev gene of visna virus is required for productive infection. Virology 1994;200:276-80.
115. Villet S, Faure C, Bouzar B, et al. Lack of trans-activation function for MVV and CAE virus Tat proteins. Virology 2003;307:317-27.
116. Villet S, Bouzar B, Morin T, Verdier G, Legras C, Chebloune Y. MVV and CAE virus genomes encode a Vpr-like but no Tat protein. J Virol 2003;77:9632-8.
117. Barros S, Andrésdóttir V, Fevereiro M. Cellular specificity and replication rate of MVV in vitro can be controlled by LTR sequences. Arch Virol 2005;150:201-13.
118. Kristbjörnsdóttir H, Andrésdóttir V, Svansson V, Torsteinsdóttir S, Matthíasdóttir S, Andrésson Ó. The vif gene of MVV is essential for infectivity in vivo and in vitro. Virology 2004;318:350-9.
119. Pétursson G, Turelli P, Matthíasdóttir S, et al. Visna virus dUTPase is dispensable for neuropathogenicity. J Virol 1998;72:1657-61.
120. Gonda M, Wong-Staal F, Gallo R, Clements J, Narayan O, Gilden R. Sequence homology and morphologic similarity of HTLV-III and visna virus, a pathogenic lentivirus. Science 1985;227:173-7.
121. Querat G, Audoly G, Sonigo P, Vigne R. Nucleotide sequence analysis of SA-OMVV, a visna-related OvLV: phylogenetic history of lentiviruses. Virology 1990;175:434-47.
122. Chadwick B, Coelen R, Sammels L, Kertayadnya G, Wilcox G. Genomic sequence analysis identifies Jembrana disease virus as a new bovine lentivirus. J Gen Virol 1995;76:189-92.
123. Grego E, Bertolotti L, Carrozza M, et al. Genetic and antigenic characterization of the matrix protein of two genetically distinct OvLV. Vet Microbiol 2005;106:179-85.
124. Andrésdóttir V. Evidence for recombination in the envelope gene of MVV. Virus Genes 2003;27:5-9.
125. Hotzel I, Cheevers W. Sequence similarity between the envelope surface unit (SU) glycoproteins of primate and small ruminant lentiviruses. Virus Res 2000;69:47-54.
126. Andrésson Ó, Elser J, Tobin G, et al. Nucleotide sequence and biological properties of a pathogenic proviral molecular clone of neurovirulent visna virus. Virology 1993;193:89-105.
127. Staskus K, Retzel E, Lewis E, et al. Isolation of replication-competent molecular clones of visna virus. Virology 1991;181:228-40.
128. Torsteinsdóttir S, Agnarsdóttir G, Matthíasdóttir S, et al. In vivo and in vitro infection with two different molecular clones of visna virus. Virology 1997; 229:370-80.
129. Andrésdóttir V. Molecular biology of MVV. In: Olsvik O, Bukholm G, ed. Application of Molecular Biology in Diagnosis of Infectious Diseases 1990 pp. 126-9.
130. Andrésdóttir V, Tang X, Agnarsdóttir G, et al. Biological and genetic differences between lung- and brain-derived isolates of MVV. Virus Genes 1998;16:281-93.
131. Andrésdóttir V, Torsteinsdóttir S Georgsson G. Neurological disease produced by MVV and CAE viruses, lentivirusues of sheep and goats. In: Gendelman H, et al. ed. The Neurology of AIDS. Oxford University Press 2005 pp 279-87.
132. Barros S, Ramos F, Duarte M, Fagulha T, Cruz B, Fevereiro M. Genomic characterization of a slow/low MVV. Virus Genes 2004;29:199-210.
133. Price R, Brew B, Sidtis J, Rosenblum M, Scheck A, Cleary P. CNS HIV-1 infection and AIDS dementia complex. Science 1988; 239:586-92.
134. Lantas P, McLaughlin J, Scholtz C, Berry C, Tighe J. Neuropathology of the brain in HIV infection. Lancet 1989;1:309-11.
135. Grieco M, Chinoy-Acharya P. Lymphocytic-interstitial pneumonia associated with AIDS. Am Rev Resp Dis 1985;131:952-5.
136. Georgsson G, Pálsson P, Pétursson G. Some comparative aspects of visna and AIDS. In: Racz P, Haase A, Gluckman J, ed. Modern Pathology of AIDS and Other Retroviral Infections. Karger, Basel 1990 pp. 82-98.
137. Pétursson G, Andrésdóttir V, Andrésson Ó, Torsteinsdóttir S, Georgsson G, Pálsson P. Review. Human and ovine lentivirus infections compared. Comp Immun Microbial Infect Dis 1991;14:277-87.
138. Gabuzda D, Hirsch M. Review. Neurologic manifestations of infection with HIV. Clinical features and pathogenesis. Am Coll Phys 1987;107:383-91.
139. Miller R, Cairns J, Bridges S, Sarver N. Minireview. HIV and AIDS: Insights from animal lentiviruses. J Virol 2000;74:7187-95.
140. Thormar H, Balzarini J, Holy A, et al. Inhibition of visna virus replication by 2′, 3′-dideoxynucleosides and acyclic nucleoside phosphonate analogs. Antimicrob Agents Chemother 1993; 37:2540-4.
141. Salvatori D, Vincenzetti S, Maury G, Gosselin G, Gaubert G, Vita A. MVV, a model for in vitro testing of potential anti-HIV drugs. Comp Immunol Microbiol Infect Dis 2001;24:113-22.
142. Thormar H, Balzarini J, Debyser Z, Witvrouw M, Desmyter J, De Clercq E. Inhibition of visna virus replication and cytopathic effect in sheep choroid plexus cell cultures by selected anti-HIV agents. Antiviral Res 1995;27:49-57.
143. Baba M, Snoeck R, Pauwels R, De Clercq E. Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus and HIV. Antimicrob Agents Chemother 1988;32:1742-5.
144. Malashkevich V, Singh M, Kim P. The trimer-of-hairpins motif in membrane fusion: Visna virus. Proc Natl Acad Sci USA 2001;98:8502-6.